BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 11502704)

  • 1. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
    Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC
    Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
    Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW
    Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells.
    Zhang S; Fantozzi I; Tigno DD; Yi ES; Platoshyn O; Thistlethwaite PA; Kriett JM; Yung G; Rubin LJ; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L740-54. PubMed ID: 12740218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
    Upton PD; Davies RJ; Tajsic T; Morrell NW
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.
    Takeda M; Otsuka F; Nakamura K; Inagaki K; Suzuki J; Miura D; Fujio H; Matsubara H; Date H; Ohe T; Makino H
    Endocrinology; 2004 Sep; 145(9):4344-54. PubMed ID: 15192043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.
    Davies RJ; Holmes AM; Deighton J; Long L; Yang X; Barker L; Walker C; Budd DC; Upton PD; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L604-15. PubMed ID: 22227206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells.
    Sheares KK; Jeffery TK; Long L; Yang X; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L919-27. PubMed ID: 15220111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
    Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
    Thomson JR; Machado RD; Pauciulo MW; Morgan NV; Humbert M; Elliott GC; Ward K; Yacoub M; Mikhail G; Rogers P; Newman J; Wheeler L; Higenbottam T; Gibbs JS; Egan J; Crozier A; Peacock A; Allcock R; Corris P; Loyd JE; Trembath RC; Nichols WC
    J Med Genet; 2000 Oct; 37(10):741-5. PubMed ID: 11015450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro.
    Dorai H; Vukicevic S; Sampath TK
    J Cell Physiol; 2000 Jul; 184(1):37-45. PubMed ID: 10825232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.
    Fantozzi I; Huang W; Zhang J; Zhang S; Platoshyn O; Remillard CV; Thistlethwaite PA; Yuan JX
    Exp Lung Res; 2005 Oct; 31(8):783-806. PubMed ID: 16368652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
    Pei L; Shan SM; Sun XY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):40-5. PubMed ID: 18346379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.
    Ogo T; Chowdhury HM; Yang J; Long L; Li X; Torres Cleuren YN; Morrell NW; Schermuly RT; Trembath RC; Nasim MT
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):733-41. PubMed ID: 23418342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TGF-beta superfamily receptors in dental pulp.
    Toyono T; Nakashima M; Kuhara S; Akamine A
    J Dent Res; 1997 Sep; 76(9):1555-60. PubMed ID: 9294489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
    You L; Kruse FE; Pohl J; Völcker HE
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.